Centene
About: Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
Employees: 60,500
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
15% more repeat investments, than reductions
Existing positions increased: 342 | Existing positions reduced: 298
3.53% more ownership
Funds ownership: 92.56% [Q1] → 96.09% (+3.53%) [Q2]
3% less funds holding
Funds holding: 886 [Q1] → 857 (-29) [Q2]
7% less capital invested
Capital invested by funds: $27.9B [Q1] → $25.9B (-$2.01B) [Q2]
11% less first-time investments, than exits
New positions opened: 111 | Existing positions closed: 125
42% less funds holding in top 10
Funds holding in top 10: 12 [Q1] → 7 (-5) [Q2]
47% less call options, than puts
Call options by funds: $130M | Put options by funds: $247M
Research analyst outlook
13 Wall Street Analysts provided 1 year price targets over the past 3 months
13 analyst ratings
Truist Securities
Ryan MacDonald
|
$39
|
Buy
Maintained
|
12 Sep 2025 |
Barclays
Andrew Mok
|
$35
|
Equal-Weight
Maintained
|
12 Sep 2025 |
Bernstein
Lance Wilkes
|
$36
|
Outperform
Maintained
|
5 Sep 2025 |
Cantor Fitzgerald
Sarah James
|
$38
|
Neutral
Reiterated
|
26 Aug 2025 |
Morgan Stanley
Ricky Goldwasser
|
$28
|
Equal-Weight
Maintained
|
4 Aug 2025 |
JP Morgan
John Stansel
|
$30
|
Neutral
Maintained
|
29 Jul 2025 |
UBS
A.J. Rice
|
$31
|
Neutral
Maintained
|
28 Jul 2025 |
Oppenheimer
Michael Wiederhorn
|
$43
|
Outperform
Maintained
|
28 Jul 2025 |
Baird
Michael Ha
|
$28
|
Neutral
Maintained
|
25 Jul 2025 |
Wells Fargo
Stephen Baxter
|
$30
|
Equal-Weight
Downgraded
|
23 Jul 2025 |
TD Cowen
Ryan Langston
|
$33
|
Hold
Downgraded
|
21 Jul 2025 |
B of A Securities
Kevin Fischbeck
|
$30
|
Underperform
Downgraded
|
16 Jul 2025 |
Mizuho
Ann Hynes
|
$40
|
Neutral
Maintained
|
11 Jul 2025 |
Financial journalist opinion
Based on 111 articles about CNC published over the past 30 days